Skip to main content
. 2022 Jun 24;23:225. doi: 10.1186/s12882-022-02845-0

Table 3.

Estimated referral rates according to different guidelines, the KFRE only and the corresponding costs, N = 1927

Guideline (year) Participants eligible for referral n, (%) Participants eligible for referral by age category, n (%) estimated referral costs (€)C according to referral criteria
 < 60 yearsa  ≥ 60 yearsb
DGfN/DGIM (2015) 159/1927 (8.3) 4 (0.4) 155 (16.5) 4,384.48
KDIGO (2012) 148/1927 (7.7) 4 (0.4) 144 (15.3) 4, 080.88
NICE (2014) 103/1927 (5.4) 3 (0.3) 100 (10.6) 2,839.86
DEGAM (2019) 95/1927 (4.9) 4 (0.4) 91 (9.7) 2,618.08
KFRE (only) 15/1927 (0.8) 3 (0.3) 12 (1.3) 411.06
NICE 2021 (incl. KFRE) 104/1927 (5.4) 4 (0.4) 100 (10.6) 2,866.48

DGfN/DGIM German Society of Nephrology/German Society of Internal Medicine, KDIGO Kidney Disease Improving Global Outcomes, NICE National Institute for Health and Care Excellence, DEGAM German College of General Practitioners and Family Physicians

a proportions based on n = 987 participants aged < 60 years, b proportions based on n = 940 participants aged ≥ 60 years. c Estimates based on a single specialist nephrologist consultation per person, excluding laboratory tests and ultrasound and biopsy, €26.62/consultation for patients < 60 years, €27.60/consultation for patients ≥ 60 years